The Clinical, Laboratory and Echocardiographic Findings of Spontaneous Echo Contrast in Patients with Atrial Fibrillation  by Çelik, Murat et al.
Results of the Study
GROUP 1 (SEC
NEFGATIVE)
(n=97)
GROUP 2 (SEC
POSITIVE)
(n=75) P value
Basal demographic and clinical features
Age, (years) 61.90  15.75 67.82  10.23 0.05
Male, n (%) 70 (72.2%) 35 (46.7%) 0.001
Heart rate, (bpm) 88.90  20.95 91.84  20.51 0.360
SBP, (mmHg) 126.55  20.79 129.05  18.46 0.414
DBP, (mmHg) 76.24  13.11 76.04  13.69 0.920
CAD, n (%) 30 (30.9%) 24 (32%) 0.881
HT, n (%) 47 (48.5%) 35 (46.7%) 0.816
HL, n (%) 20 (20.6%) 15 (20%) 0.920
DM, n (%) 27 (27.8%) 21 (28%) 0.981
Laboratory ﬁndings
Glucose, (mg/dl) 119.92  55.52 110.37  28.82 0.177
GFR, (mL/min) 71.83  21.81 64.18  24.29 0.031
LDL-C, (mg/dl) 114.23  31.77 110.11  35.27 0.447
WBC,(10.e3/microL) 7388.75  2808.06 7731.04  2264.88 0.390
HB, (g/dL) 13.33  1.98 13.41  1.69 0.779
HCT, (%) 39.96  5.62 41.08  7.28 0.258
PLT, (10.e3/microL) 238.32  77.30 247.49  77.15 0.441
PCT, (%) 0.196  0.06 0.217  0.07 0.058
MPV, (fL) 8.52  1.15 8.94  0.98 0.012
PDW, (%) 16.35  5.32 16.15  2.85 0.764
RDW, (%) 15.16  3.47 15.50  3.51 0.531
Neutrophil/Lmphocyte Ratio 3.16  2.53 3.41  2.45 0.522
Echocardiographic ﬁndings
LVIDd, (mm) 49.72  5.96 50.73  4.88 0.235
LA, (mm) 43.57  7.01 45.62  6.32 0.051
LVEF, (%) 56.79  10.53 55.61  11.12 0.480
Blood ﬂow velocity of LAA (cm/sn) 42.42  15.11 28.84  10.55 < 0.001
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Objectıve: The risk for thromboembolic events in the setting of atrial ﬁbrillation (AF)
begins with deterioration of left atrium mechanical function that is reﬂected by
development of spontaneous echo contrast (SEC). Although left atrium SEC has been
associated with a hypercoagulable state in patients with AF, the precise underlying
pathogenic mechanism behind the SEC is complex and poorly understood. The aim of
the present study is to characterize the clinical, laboratory and echocardiographic
ﬁndings of left atrial SEC.
Materıal-Methods: One hundred seventy two patients with AF in whom trans-
esophageal echocardiography was performed were enrolled to this study. Patients were
categorized according to the presence of the left atrial SEC. Group 1 was consisted of
patientswith AF and left atrial SEC (-), and group 2was consisted of patients with AF and
left atrial SEC (+). Basal demographic, laboratory and echocardiographic features of the
patientswere compared between two groups. Statistical analyses (Independent-Samples T
test and Chi-Square tests) were used to evaluate the differences between two groups.
Results: The study group was consisted of 105men (61%) and 67women (39%), and the
mean age of total patients was 64.48 13.90 years. Group 1 was consisted of 95 patientsJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POST(70 (72.2%)men,mean age 61.90 15.75 years) andGroup 2was consisted of 72 patients
(35 (46.7%) men and mean age 67.82  10.23 years). In terms of baseline demographic
characteristics, older andmale patientswithAFwere tend to have SEC in the left atrium (p
value0.05 for age, and 0.001 formale sex).Whenwe evaluated the laboratoryﬁndings,we
observed that there are statistically signiﬁcant differences for GFR and MPV values
between twogroups.SEC (+)patients had lowGFRvalues (64.18 24.29mg/dl vs. 71.83
 21.81mg/dl, p value 0.031) and higherMPVvalues (8.94 0.98 fL vs. 8.52 1.15 fL,
p value 0.012) compared with SEC (-) patients. For the echocardiographic ﬁndings,
although SEC (+) patients had large left atrium size and low left ventricular ejection
fraction, there is no a statistically signiﬁcant difference. Furthermore, peak blood ﬂow
velocity of LAA was statistically lower in SEC (+) patients compared with SEC (-) ones
(28.84  10.55 cm/sn vs. 42.42  15.11 cm/sn, p value <0.001).
Conclusıon:We found that older age, male sex, low GFR value, higher MPV value and
low blood ﬂow velocity of LAA were in association with left atrial SEC. These
mentioned patient characteristics may represent a propensity to the risk of thrombo-
embolism in the setting of left atrial SEC, and would be helpful for the better recognition
and/or managing of ongoing pathologies due to the future thromboembolic events in
patients with AF. Further prospective studies are required to identify the prognostic
signiﬁcance these risk factors in the pathogenesis of left atrial SEC in patients with AF.PP-138
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Background: TheA1298C allele is characterized by a pointmutation at position 1298 of
the methyleletetrahydrofolate reductase (MTHFR) gene causing the replacement of
glutamine by alanine in the corresponding enzyme. MTHFR gene A1298C mutation is
associated with moderately elevated homocysteine levels. Mutations in genes of the
homocysteinemetabolic pathwaymay confer an increased risk for ischemic stroke related
to elevated plasma homocysteine levels. MTHFR polymorphism has been proposed by
some studies to be also a thrombophilic risk factor for thrombosis.Atrialﬁbrillation (AF) is
the commonest sustained cardiac arrhythmia, which confers a high risk of mortality and
morbidity from stroke and thromboembolism.We aimed to investigateMTHFR A1298C
mutation in patients with AF who have had a stroke than in healthy controls.
Methods: MTHFR gene A1298C mutation was analysed in 70 patients with non-
valvuler AF who have had a stroke and 70 healthy individuals with no documented
episode of AF matched for age, race and sex. After DNA isolation, polymorphisms
were analyze using Polymerase Chain Reaction-Restriction Fragment Length Poly-
morphism methods. 1298 AA genotype is the "normal" homozygous, 1298 AC
genotype the heterozygous, and 1298 CC genotype the homozygous for the "variant".ERS C135
